Cooper Companies (NASDAQ:COO) Releases Q4 2025 Earnings Guidance

Cooper Companies (NASDAQ:COO) updated its fourth quarter 2025 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 1.100-1.140 for the period. The company issued revenue guidance of $1.0 billion-$1.1 billion. Cooper Companies also updated its FY 2025 guidance to 4.080-4.120 EPS.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on COO. JPMorgan Chase & Co. reiterated a “neutral” rating and issued a $76.00 target price (down previously from $110.00) on shares of Cooper Companies in a report on Friday, May 30th. Wall Street Zen cut Cooper Companies from a “buy” rating to a “hold” rating in a report on Saturday, July 12th. Mizuho dropped their target price on Cooper Companies from $105.00 to $90.00 and set an “outperform” rating for the company in a report on Wednesday, July 16th. Piper Sandler reiterated an “overweight” rating and issued a $105.00 target price (down previously from $115.00) on shares of Cooper Companies in a report on Friday, May 30th. Finally, BNP Paribas upgraded Cooper Companies from a “hold” rating to a “strong-buy” rating in a report on Tuesday, July 22nd. One research analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $96.73.

Cooper Companies Price Performance

COO opened at $74.11 on Thursday. The business has a fifty day moving average of $72.44 and a 200 day moving average of $77.88. Cooper Companies has a 52-week low of $65.00 and a 52-week high of $112.38. The company has a quick ratio of 1.23, a current ratio of 2.10 and a debt-to-equity ratio of 0.30. The stock has a market cap of $14.82 billion, a P/E ratio of 35.98, a PEG ratio of 1.80 and a beta of 1.00.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Wednesday, August 27th. The medical device company reported $1.10 earnings per share for the quarter, beating analysts’ consensus estimates of $1.07 by $0.03. The business had revenue of $1.06 billion during the quarter, compared to analyst estimates of $1.06 billion. Cooper Companies had a return on equity of 9.60% and a net margin of 10.39%.Cooper Companies’s revenue was up 5.7% on a year-over-year basis. During the same period in the previous year, the company posted $0.96 EPS. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. As a group, sell-side analysts anticipate that Cooper Companies will post 3.98 EPS for the current year.

Institutional Investors Weigh In On Cooper Companies

A number of institutional investors and hedge funds have recently bought and sold shares of the company. State Street Corp raised its position in Cooper Companies by 1.2% during the 2nd quarter. State Street Corp now owns 8,659,741 shares of the medical device company’s stock valued at $616,227,000 after purchasing an additional 104,910 shares in the last quarter. Ameriprise Financial Inc. raised its position in Cooper Companies by 98.8% during the 2nd quarter. Ameriprise Financial Inc. now owns 3,388,413 shares of the medical device company’s stock valued at $241,120,000 after purchasing an additional 1,683,561 shares in the last quarter. Select Equity Group L.P. raised its position in Cooper Companies by 92.5% during the 2nd quarter. Select Equity Group L.P. now owns 1,441,840 shares of the medical device company’s stock valued at $102,601,000 after purchasing an additional 692,790 shares in the last quarter. The Manufacturers Life Insurance Company raised its position in Cooper Companies by 20.4% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 1,044,949 shares of the medical device company’s stock valued at $74,359,000 after purchasing an additional 177,095 shares in the last quarter. Finally, Raymond James Financial Inc. raised its position in Cooper Companies by 4.3% during the 2nd quarter. Raymond James Financial Inc. now owns 750,787 shares of the medical device company’s stock valued at $53,426,000 after purchasing an additional 31,062 shares in the last quarter. 24.39% of the stock is owned by institutional investors.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.